@article{2f05612ccf994ed7951f1ed7ab14c26d,
title = "Hematologic reactions to carbonic anhydrase inhibitors",
abstract = "The National Registry of Drug-Induced Ocular Side effects has received 79 cases reports of suspected hematopoietic toxicity caused by carbonic anhydrase inhibitors. Twenty-six of these suspected cases (32%) resulted in death secondary to aplastic anemia, thrombocytopenia, or granulocytosis. In 54 of these 79, adverse reactions (68% occurred during the first six months of therapy).",
author = "Fraunfelder, {F. T.} and Meyer, {S. M.} and Grover Bagby and Dreis, {M. W.}",
note = "Funding Information: From the Department of Ophthalmology and the National Registry of Drug-Induced Ocular Side Effects (Dr. Fraunfelder and Ms. Meyer), the Department of Medicine-Hematology (Dr. Bagby), Oregon Health Sciences University, Portland, Oregon; and the Division of Drug Experience, the Federal Food and Drug Administration, Rockville, Maryland (Mr. Dreis). This study was supported in part by contract No. 223-82-3012 from the Food and Drug Administration, Research to Prevent Blindness, and the Helene Halliday Research Fund.",
year = "1985",
doi = "10.1016/S0002-9394(14)74987-6",
language = "English (US)",
volume = "100",
pages = "79--81",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "1",
}